Characteristic Study ID |
Intervention [route, frequency, total dose/day] |
Comparator [route, frequency, total dose/day] |
Aubertin‐Leheudre 2008 | Isoflavones capsules (orally, 4 times daily, 70 mg/day (44 mg daidzein, 16 mg glycetein, 10 mg genistein)) |
Placebo capsules (orally, 4 times daily) |
Dewell 2002 | Soy‐derived isoflavones tablets (orally, 3 times daily, 150 mg/day) |
Maltodextrin with 10% caramel colour tablets, (orally, 3 times daily, 150 mg/day) |
Gardner 2001 | 42 g soy proteins containing 80 mg aglycone isoflavones (orally, twice daily, 80 mg/day) |
42 g soy proteins containing trace amounts of isoflavones (orally, twice daily, 3 mg/day) |
Mackey 2000 | 28 g soy protein powder with 65 mg isoflavones (orally, once daily, 65 mg/day) |
28 g soy protein powder with less than 4 mg isoflavones (orally, once daily, < 4 mg/day) |
Wang 2005 | Isoflavones capsules (orally, 3 times daily, 157.5 mg/day) |
Placebo capsules (orally, 3 times daily) |